521 related articles for article (PubMed ID: 32495918)
1. Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus.
Xu P; Sun GD; Li ZZ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5797-5809. PubMed ID: 32495918
[TBL] [Abstract][Full Text] [Related]
2. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
3. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
4. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
Vargas M; Servillo G; Einav S
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
[TBL] [Abstract][Full Text] [Related]
5. An update on novel COVID-19 pandemic: a battle between humans and virus.
Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features of coronavirus disease 2019 in children: a systemic review of severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019].
He Y; Tang J; Zhang M; Wang HR; Li WX; Xiong T; Li YP; Mu DZ
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):844-853. PubMed ID: 32800031
[TBL] [Abstract][Full Text] [Related]
7. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
[TBL] [Abstract][Full Text] [Related]
8. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
9. An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19).
Naeem U; Naeem A; Naeem MA; Naeem K; Mujtaba B; Mujtaba A; Khurshid A
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9172-9181. PubMed ID: 32965011
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.
Vallamkondu J; John A; Wani WY; Ramadevi SP; Jella KK; Reddy PH; Kandimalla R
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165889. PubMed ID: 32603829
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: Look to the Future, Learn from the Past.
Cheng ZJ; Qu HQ; Tian L; Duan Z; Hakonarson H
Viruses; 2020 Oct; 12(11):. PubMed ID: 33138262
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
13. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus disease 2019: a clinical review.
Yang CL; Qiu X; Zeng YK; Jiang M; Fan HR; Zhang ZM
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4585-4596. PubMed ID: 32373999
[TBL] [Abstract][Full Text] [Related]
15. Understanding COVID-19: From Origin to Potential Therapeutics.
Moazzam M; Sajid MI; Shahid H; Butt J; Bashir I; Jamshaid M; Shirazi AN; Tiwari RK
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823901
[TBL] [Abstract][Full Text] [Related]
16. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
Al-Tawfiq JA; Memish ZA
Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
[No Abstract] [Full Text] [Related]
17. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
18. Social Distancing and Transmission-reducing Practices during the 2019 Coronavirus Disease and 2015 Middle East Respiratory Syndrome Coronavirus Outbreaks in Korea.
Jang WM; Jang DH; Lee JY
J Korean Med Sci; 2020 Jun; 35(23):e220. PubMed ID: 32537955
[TBL] [Abstract][Full Text] [Related]
19. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: The Immune Responses and Clinical Therapy Candidates.
Zhand S; Saghaeian Jazi M; Mohammadi S; Tarighati Rasekhi R; Rostamian G; Kalani MR; Rostamian A; George J; Douglas MW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
